Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire

Medical Principles and Practice

Volumn 24, Issue , 2015, Pages 38-55

  Diejomaoh, Michael F E ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Aetiology of recurrent spontaneous miscarriage; Antiphospholipid syndrome; Disease management; Parental karyotype disorder; Recurrent spontaneous miscarriage; Uterine anatomic abnormality

Indexed keywords

PROGESTERONE;

ANTIPHOSPHOLIPID SYNDROME; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; ENDOCRINE SYSTEM; GENETIC SCREENING; HEREDITY; HUMAN; IMMUNOTHERAPY; INFECTION; NATURAL KILLER CELL; PREGNANCY; RECURRENT ABORTION; RECURRENT SPONTANEOUS MISCARRIAGE; SINGLE NUCLEOTIDE POLYMORPHISM; SPONTANEOUS ABORTION; UTERINE CERVIX DISEASE; ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGE; COMPLICATION; EVIDENCE BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HEALTH SERVICE; MATERNAL WELFARE; ORGANIZATION AND MANAGEMENT; YOUNG ADULT;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; EVIDENCE-BASED MEDICINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MATERNAL HEALTH SERVICES; MATERNAL WELFARE; PREGNANCY; YOUNG ADULT;

EID: 84928637086     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000365973     Document Type: Conference Paper

References (146)

1. McNamee K, Dawood F, Farquharson R: Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol 2012; 24: 229-234.
2. Royal College of Obstetricians and Gynaecologists: The Use of Antithrombotics in the Prevention of Recurrent Pregnancy Loss. Scientific Advisory Committee Opinion Paper 26. London, RCOG Press, 2011.
3. Jauniaux E, Farquharson RG, Christiansen OB, et al: Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21: 2216-2222.
4. Christiansen OB, Nybo Anderson AM, Bosch E, et al: Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83: 821-839.
5. Royal College of Obstetricians and Gynaecologists: The Investigation and Treatment of Couples with Recurrent First-Trimester and Second-Trimester Miscarriages. Green-Top Guideline No. 17. London, RCOG Press, 2011.
6. Duckitt K, Qureshi A: Recurrent miscarriage. Clin Evid 2011; 2: 1409.
7. Coulam CB: Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991; 26: 23-27.
8. Shapira E, Ratzon R, Shoham-Vardi I, et al: Primary vs secondary recurrent pregnancy loss-epidemiological characteristics, etiology and next pregnancy outcome. J Perinat Med 2012; 40: 389-396.
9. Bashiri A, Gete S, Mazor M, et al: Recurrent pregnancy loss-evaluation and treatment. Harefuah 2011; 150: 852-856, 875.
10. Stirrat GM: Recurrent miscarriage. Lancet 1990; 336: 673-675.
11. American Society for Reproductive Medicine: Patient Fact Sheet: Recurrent Pregnancy Loss. Birmingham, American Society for Reproductive Medicine, 2008.
12. Jaslow CR, Carney JL, Kutteh WH: Diagnostic factors identified in 1, 020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010; 93: 1234-1243.
13. Cohn DM, Goddijn M, Middeldorp S, et al: Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost 2010; 8: 2208-2213.
14. American College of Obstetrics and Gynecologists Committee on Practice Bulletins: ACOG Practice Bulletin. Paper 40. Obstet Gynecol 2011.
15. Diejomaoh M, Jirous J, Al-Azemi M, et al: Insulin resistance in women with recurrent spontaneous miscarriage of unknown aetiology. Med Princ Pract 2007; 16: 114-118.
16. Patel BG, Lessey BA: Clinical assessment and management of the endometrium in recurrent early pregnancy loss. Semin Reprod Med 2011; 29: 491-506.
17. Lachmi-Epstein A, Mazor M, Bashiri A: Psychological and mental aspects and 'tender loving care' among women with recurrent pregnancy losses. Harefuah 2012; 151: 633-637, 654.
18. Nybo Anderson AM, Wohlfahrt J, Christens P, et al: Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712.
19. Bringham SA, Conlon C, Farquharson RG: A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14: 2868-2871.
20. Reagan L, Braude PR, Trembath PL: Influence of past reproductive performance on risk of spontaneous abortion. BMJ 1989; 299: 541-545.
21. De la Rochebrochard E, Thonneau P: Paternal age and maternal age are risk factors of miscarriage: results of a multicenter European study. Hum Reprod 2002; 17: 1649-1656.
22. Metwally M, Saravelos SH, Ledger WL, et al: Body mass index and risk of miscarriage in women with recurrent miscarriage. Fertil Steril 2010; 94: 290-295.
23. Metwally M, Ong KJ, Ledger WL, et al: Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception A meta-analysis of the evidence. Fertil Steril 2008; 90: 714-726.
24. Lashen H, Fear K, Sturdee DW: Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched casecontrol study. Hum Reprod 2004; 19: 1644-1646.
25. van der Berg MMJ, van Maarle MC, van Wely M, et al: Genetics of early miscarriage. Biochim Biophys Acta 2012; 1822: 1951-1959.
26. De Braekeleer M, Dao TN: Cytogenic studies in couples experiencing repeated pregnancy losses. Hum Reprod 1990; 5: 519-528.
27. Clifford K, Rai R, Watson H, et al: An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328-1332.
28. Stephenson MD, Sierra S: Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of structural chromosome rearrangement. Hum Reprod 2006; 21: 1076-1082.
29. Franssen MT, Korevaar JC, van der Veen F, et al: Reproductive outcome after chromosome analysis in couples with two or more miscarriages: index (corrected)-control study. BMJ 2006; 332: 759-763, erratum
30. BMJ 2006; 332: 1012.
31. Alijotas-Reig J, Garrido-Gimenez C: Current concepts and new trends in the diagnosis and management of recurrent miscarriage. Obstet Gynecol Surv 2013; 68: 445-466.
32. Brezina PR, Kearns WG: The evolving role of genetics in reproductive medicine. Obstet Gynecol Clin North Am 2014; 41: 41-55.
33. Brezina PR, Kutteh WH: Classic and cuttingedge strategies for the management of early pregnancy loss. Obstet Gynecol Clin North Am 2014; 41: 1-18.
34. Salim R, Regan L, Woelfer B, et al: A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 2003; 18: 162-166.
35. Grimbizis GF, Camus M, Tarlatzis BC, et al: Clinical implications of uterine malformations and hysteroscopic treatment: results. Hum Reprod Update 2001; 7: 161-174.
36. Homer HA, Li TC, Cooke ID: The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000; 73: 1-14.
37. Woelfer B, Salim R, Bannerjee S, et al: Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol 2001; 98: 1099-1103.
38. Sugiura-Ogasawara M, Ozaki Y, Suzumori N: Mullerian anomalies and recurrent miscarriage. Curr Opin Obstet Gynecol 2013; 25: 293-298.
39. De Wolf F, Carreras LO, Moerman P, et al: Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829-834.
40. Rai RS, Reagan L, Clifford K, et al: Antiphospholipid antibodies and beta-2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10: 2001-2005.
41. Lockwood CJ, Romero R, Feinberg RF, et al: The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369-373.
42. Pattison NS, Chamley LW, McKay EJ, et al: Antiphospholipid antibodies in pregnancy: prevalence and clinical association. Br J Obstet Gynaecol 1993; 100: 909-913.
43. Ernest JM, Marshburn PB, Kutteh WH: Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011; 29: 522-539.
44. Kutteh WH, Rote NS, Silver R: Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999; 41: 133-152.
45. Schust DJ, Hill JA: Recurrent Pregnancy Loss. Philadelphia, Lippincott Williams and Wilkins, 2002.
46. Kaandorp SP, Goddijn M, van der Post JA, et al: Aspirin plus heparin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586-1596.
47. McNamee K, Dawood F, Farquharson RG: Thrombophilia and early pregnancy loss. Best Pract Res Clin Obstet Gynaecol 2012; 26: 91-102.
48. Larsen EC, Christiansen OB, Kolte AM, et al: New insights into mechanisms behind miscarriage. BMC Med 2013; 11: 154.
49. Robertson L, Wu O, Langhorne P, et al: Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196.
50. Lund M, Nielsen HS, Hviid TV: Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and complications. Hum Reprod 2010; 25: 2978-2984.
51. Silver RM, Zhao Y, Spong CY, et al: Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010; 115: 14-20.
52. Sabadell J, Castellas M, Alijotas-Reig J, et al: Inherited antithrombin deficiency and pregnancy: maternal and fetal outcome. Eur J Obstet Gynecol Reprod Biol 2010; 149: 47-51.
53. Kovalevsky G, Gracia CR, Berlin JA, et al: Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis. Arch Intern Med 2004; 164: 558-563.
54. Jivraj S, Markris M, Saravelos S, et al: Pregnancy outcome in women with factor V Leiden and recurrent miscarriage. Br J Obstet Gynaecol 2009; 116: 995-998.
55. Rai R, Backos M, Elgaddal S, et al: Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum Reprod 2002; 17: 442-445.
56. Carp H, Dolitzky M, Tur-Kaspa I, et al: Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril 2002; 78: 58-62.
57. Abalovich M, Gutierrez S, Alcaraz G, et al: Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002; 12: 63-68.
58. Mills JL, Simpson H, Driscoll SG, et al: Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988; 319: 1617-1623.
59. Li TC, Spuijbroek MD, Tuckerman E, et al: Endocrinological and endometrial factors in recurrent miscarriage. Br J Obstet Gynaecol 2000; 107: 1471-1479.
60. Bussen S, Sutterlin M, Steck T: Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 1999; 14: 18-20.
61. Diejomaoh MF, Al-Azemi M, Jirous J, et al: Thyroid autoantibodies have no impact on pregnancy in women with recurrent miscarriage. ACOG abstract. Obstet Gynecol 2006; 107: 98S.
62. Rushworth FH, Backos M, Rai R, et al: Prospective pregnancy outcome in untreated recurrent miscarriages with thyroid autoantibodies. Hum Reprod 2000; 15: 1637-1639.
63. Clifford K, Rai R, Reagan L: Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997; 12: 387-389.
64. Royal College of Obstetricians and Gynaecologists: The Management of Recurrent Miscarriage. Guidelines 17. London, RCOG Press, 1998, pp 1-10.
65. Diejomaoh MFE, Al-Azemi M, Jirous J, et al: The aetiology and pattern of recurrent pregnancy loss. J Obstet Gynaecol 2002; 22: 62-67.
66. Diejomaoh M, Jirous J, Al-Azemi M, et al: The relationship of recurrent spontaneous miscarriage with reproductive failure. Med Princ Pract 2003; 12: 107-111.
67. Cocksedge KA, Saravellos SH, Metwally M, et al: How common is polycystic ovary syndrome in recurrent miscarriage Reprod Biomed Online 2009; 19: 572-576.
68. Craig LB, Ke RW, Kutteh WH: Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002; 78: 487-490.
69. Diejomaoh M, Jirous J, Al-Azemi M, et al: Insulin resistance in women with recurrent miscarriage of unknown aetiology. Med Princ Pract 2007; 16: 114-118.
70. Wang Y, Zhao H, Li Y, et al: Relationship between recurrent miscarriage and insulin resistance. Gynecol Obstet Invest 2011; 72: 245-251.
71. Lee RM, Silver RM: Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med 2000; 18: 433-440.
72. Dosiou C, Giudice LC: Natural killer cells in pregnancy and recurrent pregnancy loss. Endocrine and immunologic perspectives. Endocr Rev 2005; 26: 44-62.
73. Moffett A, Reagan L, Braude P: Natural killer cells, miscarriage and infertility. BMJ 2004; 329: 1283-1285.
74. Cooper MA, Fehniger TA, Caligiur MA: The biology of human natural killer cell subsets. Trends Immunol 2001; 22: 633-640.
75. Tang AW, Alfiveric Z, Quenby S: Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systemic review. Hum Reprod 2011; 26: 1971-1980.
76. Nagler A, Lanier LL, Cwirla S, et al: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183-3191.
77. King A, Balendran N, Wooding P, et al: CD3 leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev Immunol 1991; 1: 169-190.
78. Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and infertile women with failed in-vitro fertilization cycles. Am J Reprod Immunol 1996; 35: 376-382.
79. Gregory CD, Lee H, Rees GB, et al: Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single cell cytotoxicity assays. Clin Exp Immunol 1987; 62: 121-127.
80. Lachapelle MH, Miron P, Hemmings R, et al: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-4034.
81. Nitrivalas EI, Kwam-Kim JYH, Gilman-Sachs A, et al: Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum Reprod 2001; 16: 855-861.
82. Kwak JYH, Beaman KD, Gilman-Sachs A, et al: Up-regulated expression of CD56+, CD56+/CD16+ and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent spontaneous abortions. Am J Reprod Immunol 1995; 34: 93-99.
83. Gilman-Sachs A, Du Chateau BK, Aslakson CJ, et al: Natural killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41: 99-105.
84. Chaout G, Ledee-Bataille N, Zourbass S: Cytokines, implantation and early abortion: reexamining the Th1/Th2 paradigm leads to question in the single pathway. Single therapy concept. Am J Reprod Immunol 2003; 50: 177-186.
85. Chaout G, Ledee-Bataille N, Dubanchet S, et al: Reproductive immunology 2003: reassessing the Th1/Th2 paradigm. Immunol Lett 2004; 92: 207-214.
86. Wegman TG, Lin H, Guilbert L, et al: Bidirectional cytokine interaction in the maternalfetal relationship: is successful pregnancy a Th2 phenomenon Immunol Today 1993; 14: 353-356.
87. Daher S, Mattar R, Gueuvoghlanian-Silva BY, et al: Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol 2012; 67: 341-347.
88. Reagan L, Jivraj S: Infection and pregnancy loss; in Maclean AB, Reagan L, Carrington D (eds): Infection and Pregnancy. London, RCOG Press, 2001, pp 291-304.
89. Summers PR: Microbiology relevant to recurrent miscarriage. Clin Obstet Gynecol 1994; 37: 722-729.
90. Diejomaoh MFE, Rotimi VO, Omu AE, et al: Correlation between bacterial vaginosis and adverse pregnancy outcome. Med Princ Pract 1999; 8: 167-254.
91. Rotimi VO, Diejomaoh FME, Omu AE, et al: The prevalence of bacterial vaginosis and vaginosis-associated pathogens in pregnant women in Kuwait. Kuwait Med J 1999; 31: 251-256.
92. Leitich H, Kiss H: Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2007; 21: 375-390.
93. Hay PE, Lamont RF, Taylor-Robinson D, et al: Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308: 295-298.
94. Brocklehurst P, Hannah M, McDonald H: Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2000;CD000262.
95. Robert JM, Macara LM, Chalmers EA, et al: Inter-assay variations in antiphospholipid antibody testing. Br J Obstet Gynaecol 2002; 109: 348-349.
96. van Dunne FM, Doggen CJ, Heemskerk M, et al: Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 2005; 20: 802-806.
97. Beaman KD, Ntrivalas E, Mallers TM, et al: Immune etiology of recurrent pregnancy loss and its diagnosis. Am J Reprod Immunol 2012; 67: 319-325.
98. Royal College of Obstetricians and Gynaecologists: The Investigation and Treatment of Couples with Recurrent Miscarriage. Guideline No. 17. London, RCOG Press, 2003.
99. Reagan L, Rai R, Backos M, et al: Recurrent miscarriage and parental karyotype abnormalities: prevalence and future pregnancy outcome. Abstracts of the 17th Annual Meeting of the ESHRE, Lausanne, Switzerland, 2001. Hum Reprod 2001; 16(suppl 1):177-178.
100. Fransen MT, Musters AM, van der Veen F, et al: Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review. Hum Reprod Update 2011; 17: 467-475.
101. Lalioti MD: Can preimplantation genetic diagnosis overcome recurrent pregnancy failure Curr Opin Obstet Gynecol 2008; 20: 199-204.
102. Ogilvie CM, Braude P, Scriven P: Successful pregnancy outcomes after preimplantation genetic diagnosis (PGD) for carriers of chromosome translocations. Hum Fertil (Camb) 2001; 4: 168-171.
103. Scriven PN, Flinter FA, Braude PR, et al: Robertsonian translocations-reproductive risks and indications for preimplantation genetic diagnosis. Hum Reprod 2001; 16: 2267-2273.
104. Kowalik CR, Goddijn M, Emanuel MH, et al: Metroplasty versus expectant management for women with recurrent miscarriage and a septate uterus. Cochrane Database Syst Rev 2011; 6:CD008576.
105. Gibbs DM, Salaria DA: Transabdominal cervicoisthmic cerclage in the management of recurrent second trimester miscarriage and preterm delivery. Br J Obstet Gynaecol 1995; 102: 802-806.
106. Anthony GS, Walker RG, Cameron AD, et al: Transabdominal cervico-isthmic cerclage in the management of cervical incompetence. Eur J Obstet Gynecol Reprod Biol 1997; 72: 127-130.
107. Debbs RH, DeLa Vega GA, Pearson S, et al: Transabdominal cerclage after comprehensive evaluation of women with previous unsuccessful transvaginal cerclage. Am J Obstet Gynecol 2007; 197: 317.e1-e4.
108. Zaveri V, Aghajafari F, Amankwah K, et al: Abdominal versus vaginal cerclage after a failed transvaginal cerclage: asystematic review. Am J Obstet Gynecol 2002; 187: 868-872.
109. Thuesen LL, Dines BR, Langhoff-Roos J: Pre-pregnancy transabdominal cerclage. Acta Obstet Gynecol Scand 2009; 88: 483-486.
110. Rai R, Regan L: Recurrent miscarriage. Lancet 2006; 368: 601-611.
111. Miyakis S, Lockshin MD, Atsumi T, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
112. Practice Committee of the American Society for Reproductive Medicine: Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98: 1103-1111.
113. Bates SM, Greer IA, Pabinger I, et al; American College of Chest Physicians: Venous thromboembolism, thrombophilia, antithrombolic therapy and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 844S-886S.
114. Empson MB, Lassere M, Craig JC, et al: Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005;CD002859.
115. Maki A, Cheung WW, Cheak AA, et al: Combination of heparin and aspirin is superior to aspirin alone in enhancing births in patients with recurrent pregnancy loss and positive antiphospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 2010; 49: 281-288.
116. Diejomaoh MFE, Al-Azemi MM, Bandar A, et al: A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome. Arch Gynecol Obstet 2002; 266: 61-66.
117. American College of Obstetricians and Gynecologists: Committee on Practice Bulletins-Obstetrics: ACOG Practice Bulletin No. 118: antiphospholipid syndrome. Obstet Gynecol 2011; 117: 192-199.
118. Noble LS, Kutteh WH, Lashey N, et al: Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low molecular weight heparin versus unfractionated heparin. Fertil Steril 2005; 83: 684-690.
119. Stephenson MD, Ballem PJ, Tsang P, et al: Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004; 26: 729-734.
120. Farquharson RG, Quenby S, Greaves M: Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408-413.
121. Laskin CA, Spitzer KA, Clark CA, et al: Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized controlled HepASA Trial. J Rheumatol 2009; 36: 279-287.
122. Rai R, Cohen H, Dave M, et al: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.
123. Ogueh O, Chen MF, Spurll G, et al: Outcome of pregnancy in women with hereditary thrombophilia. Int J Gynaecol Obstet 2001; 74: 247-253.
124. Carp H, Dolitzky M, Inbal A: Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003; 1: 443-448.
125. Brenner B, Hoffman R, Carp H, et al: Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost 2005; 3: 227-229.
126. Viser J, Ulander VM, Helmerhorst FM, et al: Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicenter trial. J Thromb Haemost 2010; 105: 295-301.
127. Royal College of Obstetricians and Gynaecologists: Cervical Cerclage. Green-Top Guideline No. 60. London, RCOG Press, 2011.
128. Drakeley AJ, Roberts D, Alfirevic Z: Cervical cerclage for prevention of preterm delivery: meta-analysis of randomized trials. Obstet Gynecol 2003; 102: 621-627
129. erratum in Obstet Gynecol 2004; 103: 201.
130. Berghella V, Odibo AO, To MS, et al: Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181-189.
131. Csapo AL, Pulkien MO, Ruttner B, et al: The significance of the human corpus luteum in pregnancy maintenance. Am J Obstet Gynecol 1972; 112: 1061-1067.
132. Goldstein P, Berrier J, Rosen HS, et al: A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989; 96: 265-274.
133. Keirse MJ: Progestogen administration in pregnancy may prevent preterm delivery. A meta-analysis. Br J Obstet Gynaecol 1990; 97: 149-158.
134. Raghupathy R, Al-Muttawa E, Al-Azemi M, et al: Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol 2009; 80: 91-99.
135. Haas DM, Ramsey PS: Progesterone for preventing miscarriage. Cochrane Database Syst Rev 2008; 2:CD003511.
136. Omar MH, Mashifa MK, Lim PS, et al: Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol 2005; 97: 421-425.
137. El-Zibdeh MY: Dydrogesterone in the reduction of recurrent spontaneous abortion. J Steroid Biochem Mol Biol 2005; 97: 431-434.
138. Porter TF, LaCoursiere Y, Scott JR: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006;CD0000112.
139. Stephenson MD, Kutteh WH, Purkiss S, et al: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo controlled trial. Hum Reprod 2010; 25: 2203-2209.
140. Ata B, Tan SL, Shehata F, et al: A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril 2011; 96: 1080-1085.
141. Christiansen OB, Pedersen B, Rosgaard A, et al: A randomized double-blind, placebo controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence of a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002; 17: 809-816.
142. Perricone R, Di Muzio G, Perricone C, et al: High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulin. Am J Reprod Immunol 2006; 55: 232-239.
143. Coulam CB, Acacia B: Does immunotherapy for treatment of reproductive failure enhance live births Am J Reprod Immunol 2012; 67: 296-303.
144. Stray-Pedersen B, Stray-Pedersen S: Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 1984; 148: 140-146.
145. Liddel HS, Pattison NS, Zanderigo A: Recurrent miscarriage-outcome after supportive care in early pregnancy. Aust NZ J Obstet Gynaecol 1991; 31: 320-322.
146. Clark P, Walker ID, Langhorne PC, et al: Scottish pregnancy intervention study (SPIN) collaborators. SPIN (Scottish Prevention Intervention) study: a multicenter, randomized controlled trial of low-molecular weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115: 4162-4167.